Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Cervical Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Genitourinary System Neoplasm
Reproductive System Neoplasm
Female Reproductive System Neoplasm
Uterine Neoplasm
Cervical Neoplasm

Subtype

Cervical Neoplasm

CI-CAN-00004801Explore in graph →

Non-malignant573 active trials4 approved drugs14 evidence items

NCIt: C2940
MeSH: D002583

Overview
Statistics
Survival
Genomics7
Variants & evidence14
Drugs8
Trials2386
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (111)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 101–111 of 111 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Toward the molecular dissection of peritoneal pseudomyxoma.
· Ann Oncol · 2016 · PMID 27502722 · validated civic_curation pubmed
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
· J Transl Med · 2016 · PMID 27154293 · validated civic_curation pubmed
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.
· J Clin Oncol · 2025 · PMID 39413348 · validated civic_curation pubmed
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
· Oncotarget · 2015 · PMID 26311741 · validated civic_curation pubmed
TP53 polymorphism, HPV infection, and risk of cervical cancer.
· Cancer Epidemiol Biomarkers Prev · 2001 · PMID 11535556 · validated civic_curation pubmed
A novel K-ras mutation in colorectal cancer. A case report and literature review.
· Anticancer Res · 2009 · PMID 19661358 · validated civic_curation pubmed
EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review.
· Front Med (Lausanne) · 2022 · PMID 35572973 · validated civic_curation pubmed

Showing 101–111 of 111 publications

← Previous
1
…
4
5
Next →

AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol.

· Cancer Cell · 2003 · PMID 12559175 · validated civic_curation pubmed

Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.

· Oncotarget · 2016 · PMID 27489350 · validated civic_curation pubmed

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.

· Mol Oncol · 2013 · PMID 23415752 · validated civic_curation pubmed

Le Gallo et al. Cancer 2017

· 2017 · PMID 28485815 · validated cbioportal_study pubmed